Seth Carter, DO
Geriatric Medicine · Erie, PANPI 1689024598
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,927 of the $13,982 with a category attached, or 71.0%. 59 manufacturers reported payments, led by Lilly USA, LLC at 37.4% of the total. 2025 is the largest year on record at $6,643, more than ten times the $85 reported in 2019. Among geriatric medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 582 payments — averaging $24.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$5K
- Pfizer$1K
- Novo Nordisk$782
- Teva Pharmaceuticals USA, Inc.$450
- Merck$447
- AbbVie$417
- plus $6K from 53 others
What the payments were for
- Consulting fees$4,05029%
- Food & beverage$9,92771%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KISUNLA$4,050
- VenaSeal$145
- InFrame Implant$128
- ACUMED$128
How this compares
$13,982 in reported general payments places this provider in the 95th percentile of 217 geriatric medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 199 | $111,099 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 131 | $84,169 |
| JardianceEmpagliflozin | 64 | $64,847 |
| OzempicSemaglutide | 56 | $60,314 |
| XareltoRivaroxaban | 77 | $57,295 |
| RexultiBrexpiprazole | 58 | $56,817 |
| GlatopaGlatiramer Acetate | 12 | $44,872 |
| TrulicityDulaglutide | 51 | $44,376 |
| FarxigaDapagliflozin Propanediol | 23 | $23,874 |
| NuedextaDextromethorphan Hbr/Quinidine | 16 | $21,461 |
| MyrbetriqMirabegron | 31 | $17,491 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 38 | $17,124 |
| MounjaroTirzepatide | 13 | $13,544 |
| Atorvastatin Calcium | 772 | $11,356 |
| EntrestoSacubitril/Valsartan | 22 | $10,964 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $360 | $111,620192 claims |
| PfizerEliquis | $1,055 | $111,099199 claims |
| Boehringer IngelheimJardiance | $385 | $64,84764 claims |
| Novo NordiskOzempic | $782 | $60,31456 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $5,230 | $57,92064 claims |
| Johnson & JohnsonXarelto | $188 | $57,29577 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $134 | $56,81758 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $383 | $34,66740 claims |
| NovartisEntresto | $70 | $10,96422 claims |
| Sanofi-aventis U.S. LLCLantus | $17 | $6,67589 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $68 | $5,965612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 217 geriatric medicine providers in Pennsylvania.
Other geriatric medicine in Erie
- James LinErie$73K
- Danielle HansenErie$5K
- Douglas FronzagliaErie$897
- Dorothy CandibErie$471
- Richard StefanacciPhiladelphia$146K
- Adele TowersPittsburgh$29K
- Michele ZaworaPhiladelphia$21K
- Daniel HaimowitzLevittown$15K
- Robert PearlsteinPlymouth Meeting$15K
- Moushumi KunduHanover$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.